There have been attempts to increase BAT activation with sympathomimetics, as it is a tissue capable of extensive energy expenditure [3], in order to treat obesity and diabetes by mimicking the effect of norepinephrine on β3-AR. The gene discussed is ADRB3; the disease is obesity due to melanocortin 4 receptor deficiency.